WallStreetZenWallStreetZen

NASDAQ: IMVT
Immunovant Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IMVT

Based on 10 analysts offering 12 month price targets for Immunovant Inc.
Min Forecast
$32.00-18.22%
Avg Forecast
$45.60+16.53%
Max Forecast
$57.00+45.67%

Should I buy or sell IMVT stock?

Based on 10 analysts offering ratings for Immunovant Inc.
Strong Buy
Strong Buy
8 analysts 80%
Buy
2 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMVT stock forecasts and price targets.

IMVT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-15
lockedlocked$00.00+00.00%2023-10-24Find Out Why
lockedlocked$00.00+00.00%2023-10-24
lockedlocked$00.00+00.00%2023-10-16
lockedlocked$00.00+00.00%2023-10-13
Wells Fargo
Top 2%
99
Strong BuyMaintains$48.00+22.67%2023-09-27Find out why
Citigroup
Top 34%
67
Strong BuyMaintains$50.00+27.78%2023-09-27
Raymond James
Bottom 6%
6
BuyUpgrades$40.00+2.22%2023-09-27
Guggenheim
Bottom 10%
10
Strong BuyReiterates$32.00-18.22%2023-09-22
Stifel Nicolaus
Top 17%
84
Strong BuyMaintains$34.00-13.11%2023-07-18Find out why

1 of 1

Forecast return on equity

Is IMVT forecast to generate an efficient return?
Company
-83.3%
Industry
-0.68%
Market
30.08%
IMVT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMVT forecast to generate an efficient return on assets?
Company
-71.82%
Industry
-0.19%
IMVT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMVT revenue forecast

What is IMVT's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$59.3M
Avg 2 year Forecast
$329.0M
Avg 3 year Forecast
$655.6M

IMVT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMVT$39.13$45.60+16.53%Strong Buy
ASND$100.43$136.60+36.02%Buy
ABCM$23.97$23.00-4.05%Buy
CRSP$66.73$74.27+11.30%Buy
HALO$38.61$54.25+40.51%Strong Buy
View Top Biotech Stocks

Immunovant Stock Forecast FAQ

Is Immunovant Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: IMVT) stock is to Strong Buy IMVT stock.

Out of 10 analysts, 8 (80%) are recommending IMVT as a Strong Buy, 2 (20%) are recommending IMVT as a Buy, 0 (0%) are recommending IMVT as a Hold, 0 (0%) are recommending IMVT as a Sell, and 0 (0%) are recommending IMVT as a Strong Sell.

If you're new to stock investing, here's how to buy Immunovant stock.

What is IMVT's revenue growth forecast for 2026-2028?

(NASDAQ: IMVT) Immunovant's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Immunovant's revenue in 2023 is $0.On average, 4 Wall Street analysts forecast IMVT's revenue for 2026 to be $8,581,635,011, with the lowest IMVT revenue forecast at $1,994,888,015, and the highest IMVT revenue forecast at $11,789,947,295. On average, 4 Wall Street analysts forecast IMVT's revenue for 2027 to be $47,592,328,351, with the lowest IMVT revenue forecast at $12,495,897,513, and the highest IMVT revenue forecast at $83,018,588,388.

In 2028, IMVT is forecast to generate $94,833,417,535 in revenue, with the lowest revenue forecast at $32,569,186,920 and the highest revenue forecast at $165,850,562,887.

What is IMVT's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: IMVT) forecast ROA is -71.82%, which is lower than the forecast US Biotechnology industry average of -0.19%.

What is IMVT's Price Target?

According to 10 Wall Street analysts that have issued a 1 year IMVT price target, the average IMVT price target is $45.60, with the highest IMVT stock price forecast at $57.00 and the lowest IMVT stock price forecast at $32.00.

On average, Wall Street analysts predict that Immunovant's share price could reach $45.60 by Nov 15, 2024. The average Immunovant stock price prediction forecasts a potential upside of 16.53% from the current IMVT share price of $39.13.

What is IMVT's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: IMVT) forecast ROE is -83.3%, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.